Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-025410

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Jul 20, 2016
Accepted (ET)
Jul 21, 2016 · 7:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 20, 2016M4,410$0.48A6,910D
Common StockF1Jul 20, 2016M8,829$0.96A15,739D
Common StockF1Jul 20, 2016M16,146$2.64A31,885D
Common StockF2holding———266,616IBy Trust
Common Stockholding———14,835IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$0.48Jul 20, 2016M4,410D—Jun 12, 2022Common Stock4,4100D
Employee Stock Option (Right to Buy)F4$0.96Jul 20, 2016M8,829D—May 22, 2023Common Stock8,82913,874D
Employee Stock Option (Right to Buy)F5$2.64Jul 20, 2016M16,146D—Dec 16, 2023Common Stock16,14647,919D
Employee Stock Option (Right to Buy)F4$0.96Jul 20, 2016M7,586D—May 22, 2023Common Stock7,58611,920I
Employee Stock Option (Right to Buy)F5$2.64Jul 20, 2016M4,749D—Dec 16, 2023Common Stock4,74914,247I

Explanation of responses